Open-label placebo for chronic low back pain: A 5-year follow-up

Back Pain

Effects of open-label placebo on pain, functional disability and spine mobility in chronic back pain patients: a randomized controlled trial

Pain.

Kleine-Borgmann J, Schmidt K, Hellmann A, Bingel U

doi: 10.1097/j.pain.

Back PainChronic Pain

The Impact of Anxiety and Depression on the Outcomes of Chronic Low Back Pain Multidisciplinary Pain Management-A Multicenter Prospective Cohort Study in Pain Clinics with One-Year Follow-up

Pain Med.

Oliveira DS, Vélia Ferreira Mendonça L, Sofia Monteiro Sampaio R, Manuel Pereira Dias de Castro-Lopes J, Ribeiro de Azevedo LF

doi: 10.1093/pm/pny128.

COMMENTED

Back Pain

Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain

doi: 10.1001/jamainternmed.

Back Pain

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

Pain.

Markman JD, Bolash RB, McAlindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer FW, Li DJ, Viktrup L, Bramson C, West CR, Verburg KM

doi: 10.1097/j.pain.0000000000001928.

Back Pain

A randomized placebo-controlled trial of desipramine, cognitive behavioral therapy, and active placebo therapy for low back pain

Pain.

Gould HM, Atkinson JH, Chircop-Rollick T, D'Andrea J, Garfin S, Patel SM, Funk SD, Capparelli EV, Penzien DB, Wallace M, Weickgenant AL, Slater M, Rutledge T

doi: 10.1097/j.pain.0000000000001834.

Back PainChronic Pain

Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain

Eur J Pain.

Schliessbach J, Vuilleumier PH, Siegenthaler A, Bütikofer L, Limacher A, Juni P, Zeilhofer HU, Arendt-Nielsen L, Curatolo M

doi: 10.1002/ejp.1032.

Back PainChronic Pain

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials

J Pain Res.

Alev L, Fujikoshi S, Yoshikawa A, Enomoto H, Ishida M, Tsuji T, Ogawa K, Konno S

doi: 10.2147/JPR.S138297.

Back PainChronic Pain

Variability in negative emotions among individuals with chronic low back pain: relationships with pain and function

Pain.

Gerhart JI, Burns JW, Bruehl S, Smith DA, Post KM, Porter LS, Schuster E, Buvanendran A, Fras AM, Keefe FJ

doi: 10.1097/

Back PainChronic Pain

The relationship between catastrophizing and altered pain sensitivity in patients with chronic low-back pain

Pain.

Meints SM, Mawla I, Napadow V, Kong J, Gerber J, Chan ST, Wasan AD, Kaptchuk TJ, McDonnell C, Carriere J, Rosen B, Gollub RL, Edwards RR

doi: 10.1097/j.pain.0000000000001461.

Related content

Effects of open-label placebo on pain, functional disability and spine mobility in chronic back pain patients: a randomized controlled trial

The Impact of Anxiety and Depression on the Outcomes of Chronic Low Back Pain Multidisciplinary Pain Management-A Multicenter Prospective Cohort Study in Pain Clinics with One-Year Follow-up

Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

A randomized placebo-controlled trial of desipramine, cognitive behavioral therapy, and active placebo therapy for low back pain

Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials

Variability in negative emotions among individuals with chronic low back pain: relationships with pain and function

The relationship between catastrophizing and altered pain sensitivity in patients with chronic low-back pain